ROBERTS EIRY sold NBIX

February 14, 2025 · Form 4 insider transaction

ROBERTS EIRY sold 500 shares of Neurocrine Biosciences, Inc. at $115.04 per share, a transaction worth $57.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
500
Price
$115.04
Total value
$57.5K
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 14, 2025
Filing dateFebruary 14, 2025
Shares owned after35,640
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $114.76 to $115.15. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.; 34,455 of the outstanding shares are held by The Stephen Taylor and Eiry W. Roberts Joint Trust Agreement, of which Dr. Roberts has voting and investment power.

View the original Form 4 on SEC EDGAR